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Does smoking cessation counseling improve success rates in adult smokers who desire to quit compared to both
pharmacologic therapy for cessation and no therapy or counseling?
Madison Pribble & Trevor Leonard
Longwood University Nursing Class of 2023

Abstract
This research is aimed to answer the question: does smoking cessation counseling (I) improve success rates (O) in adult smokers who
desire to quit (P) compared to pharmacologic therapy for cessation and no therapy or counseling (C)? We looked at health-related
literature to determine which method of smoking cessation had the highest success rates. In our research we expected to find that
success rates were greatest when individuals had a combination of pharmacotherapy in conjunction with counseling. A report of the
Surgeon General compiled results of studies reporting the efficacy of numerous cessation therapies and their success. Our research of
these and other reports supported our expectation. Medication and counseling both have roles in smoking cessation and have led to
higher success rates in smoking individuals. We concluded that patients who wish to quit smoking should try counseling first and, if
needed, use pharmacotherapy to aid in smoking cessation as the combination of both therapies has the highest success rate.

Introduction
Cigarette use is the leading cause of preventable disease and death in the United States, killing more than 480,000 individuals each year
(Centers for Disease Control and Prevention, 2021b). The United States spends over $300 billion dollars each year on smoking related
illnesses. Smoking cessation improves health and reduces individuals risk of heart disease, stroke, lung disease, cancer, and other
smoking-related illnesses (U.S. Food and Drug Administration, 2017). Treatments that support smoking cessation include behavioral
therapies and FDA approved pharmacotherapy. However, fewer than one third of smokers who attempt to quit smoking use proven
treatments (Centers for Disease Control and Prevention, 2020). Behavioral therapy helps individuals make long-term changes to
behavior to aid in removing tobacco from one's life, while medications can help with physical cravings caused by nicotine addiction
(U.S. Department of Veterans Affairs, 2021). Smoking has a major impact on the health of individuals, so this research allowed us to
conclude the best ways to improve the success rates of smoking cessation.

Methods
Throughout this project we researched, appraised, and synthesized nursing and health-related literature to determine the success rates of counseling,
pharmacological therapy, or no therapy to improve smoking cessation. Articles and reports were chosen based on relevancy and credibility of the
sources. The Surgeon General's report is focused on adult cessation of cigarette use which is in line with our desired population. Numerous studies
cited in the Surgeon General's report were read by both participating researchers to ensure accurate interpretation of the studies results (U.S.
Department of Health and Human Services, 2020). Chosen studies from the report were analyzed for conflicts of interest and the qualifications of
the authors, as well as the age of the research. Studies used which were over 5 years old were determined to be relevant based on the scope and
source of the study. For example, Figure 1 is pulled from a study sanctioned by the United Kingdom and its methods and therapies are still widely
used (Kotz et al., 2013). Additional articles from health related sites were used to support our research findings and held to the same standards.

Research
Current evidence based treatment for smoking cessation include behavioral therapies and pharmacotherapy (U.S. Department of
Health and Human Services, 2020). In 2018, 7.5% of adult smokers had successfully quit smoking within the past year and 61.7% who
had ever smoked had quit (Centers for Disease Control and Prevention, 2020). Smokers who attempt to quit without assistance have
success rates of seven to eight percent (U.S. Department of Health and Human Services, 2020). Research has shown that the use of
FDA approved cessation medications such as Nicotrol can double a smokers chance of quitting (U.S. Food and Drug Administration,
2017). Nicotine is the main substance responsible for causing addiction in these individuals. Nicotine replacement therapy supplies
nicotine in small amounts without the other chemicals contained in tobacco products. It is delivered through patches, chewing gum, or
lozenges. This therapy can be used for a short time to manage cravings and withdrawal (U.S. Food and Drug Administration, 2017). It
provides a lower plasma nicotine concentration when used as intended which reduces the behaviorally reinforcing effect of smoking
(U.S. Department of Health and Human Services, 2020). Chantix and Zyban are two cessation products that do not contain nicotine.
Chantix acts in the brain to reduce the rewarding effects of nicotine diminishing a smoker’s desire to use tobacco products (U.S. Food
and Drug Administration, 2017). Other pharmacotherapy options include Bupropion and Varenicline (U.S. Department of Health and
Human Services, 2020). Behavioral strategies that have been effective in smoking cessation include cognitive behavioral therapy,
motivational interviewing, and acceptance and commitment therapy (U.S. Department of Health and Human Services, 2020).
Behavioral therapy is delivered over several weeks with a focus of physiological, psychological, social, and environmental aspects of
smoking and dependence. Research has shown that pharmacotherapy and behavioral therapy used alone can increase cessation rates,
but a combination of both is most effective (U.S. Department of Health and Human Services, 2020). A review of 27 trials with over
11,000 participants, conducted in 2016, showed that individual counseling can increase the chance of cessation by 40% to 80%
(Lancaster & Stead, 2017) . 40 studies with 15,000 participants showed there was a significant increase in smoking cessation when
pharmacotherapy was combined with behavioral treatment (U.S. Department of Health and Human Services, 2020).
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Results
Through our research we concluded that both pharmacotherapy and counseling have a positive impact on smoking
cessation; however, a combination of both has a greater effect (Babb et al., 2017). The evidence indicated that the
chances of successfully sustaining smoking cessation and avoiding relapse increases with evidence-based cessation
therapies, which is further increased with a higher dose, duration, and intensity of treatment (U.S. Department of
Health and Human Services, 2020). Studies which specifically recorded cessation outcomes of pharmacologic
therapy, support, and a combination of both found that combining drug and emotional therapy to have dramatic
improvements on success rates. A study in England with over 10,000 participants found that psychological and
pharmacological therapy combinations could result in over double the success rate compared to single therapy
treatments (Kotz et al., 2013). Below shown in Figure 1 is the collected data of this study.
Figure 2

Figure 1

‘Real-world’ Effectiveness of Smoking Cessation Treatments

Use of Cessation Support Among Adults who Tried to Quit Smoking

Evaluation and Analysis
We researched this topic because smoking can lead to numerous complications including long term disease, general
decrease in health, cancer, and even death. Cessation improves health and reduces individuals’ risk of many smoking
related illnesses such as lung disease, cancer, and heart disease (U.S. Food and Drug Administration, 2017).
Smoking cessation has many other benefits including breathing more easily, increased energy, stress reduction,
fertility improvement, smell and taste improvement, and can lead to a longer life (National Health Service, 2018). No
matter how long a smoker has used tobacco, cessation has health benefits. We felt that it was important to find
evidence in numerous studies as to the most successful cessation methods. Beyond quitting cold turkey and over the
counter nicotine replacement, prescription pharmacologic therapy and psychological therapy are the only other
prominent methods of cessation. We focused on the objective results of studies comparing these four ubiquitous
methods of cessation to draw conclusions.

Conclusions and Implications for Future Research
Smoking cessation is important for all age groups (Babb et al., 2017). It is important for healthcare providers and nurses to
identify smokers, advise them to quit, and offer evidence-based cessation treatments. Unaided quitting often occurs due to
inadequate insurance coverage, inadequate promotion of cessation treatments, underfunding of state cessation programs, and
inadequate screening in clinical care (U.S. Department of Health and Human Services, 2020). Funding state tobacco control
programs, increasing tobacco product prices, implementing smoke-free policies, conducting cessation campaigns, and increasing
access to smoking cessation therapy can aid in increasing smoking cessation, and reduce the risk of disease and death (Babb et al.,
2017). Education regarding life changes, disease diagnosis, medical procedures, and screening results can motivate patients to
smoking cessation (U.S. Department of Health and Human Services, 2020). The use of smoking cessation interventions remains
low, so it is important to research and apply evidence-based research to increase the knowledge and use of these therapies (Babb
et al. 2017). In the future, research should be conducted to determine which pharmacotherapy has the highest success rates and
how to improve smokers knowledge of smoking cessation therapy options. Research into the surprisingly low use of cessation
support, as shown in Figure 2, could be done to determine why so few individuals who try to quit smoking utilize existing support
structures and cessation products (Centers for Disease Control and Prevention, 2021a). Knowing what cessation techniques are
the most effective is of little help if it is not understood how to increase smokers’ use of these resources.
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Figure 1

This chart shows the percentage of successful quit attempts for individuals who used medications with behavioral support, medications without
behavioral support, over the counter nicotine replacement therapy, and no behavioral or pharmacotherapy support (Kotz et al., 2013). This data was
obtained from a study in England of 10,335 participants who had smoked within the previous 12 months and had made at least one quit attempt (Kotz
et al., 2013).
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Figure 2

In a study of 31 countries between 2008 and 2018, the above graph shows the median percentage of the use of
smoking cessation support among adults 15 years of age or older who currently smoked tobacco and had made a quit
attempt in the past 12 months (Centers for Disease Control and Prevention, 2021a).
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